Pulmonary fibrosis: from pathogenesis to clinical decision-making.

Koudstaal, Thomas; Funke-Chambour, Manuela; Kreuter, Michael; Molyneaux, Philip L; Wijsenbeek, Marlies S (2023). Pulmonary fibrosis: from pathogenesis to clinical decision-making. Trends in molecular medicine, 29(12), pp. 1076-1087. Cell Press 10.1016/j.molmed.2023.08.010

Text 1-s2.0-S1471491423001958-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB)

Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that progressively impact the interstitium, resulting in compromised gas exchange, breathlessness, diminished quality of life (QoL), and ultimately respiratory failure and mortality. Various diseases can cause PF, with their underlying causes primarily affecting the lung interstitium, leading to their referral as interstitial lung diseases (ILDs). The current understanding is that PF arises from abnormal wound healing processes triggered by various factors specific to each disease, leading to excessive inflammation and fibrosis. While significant progress has been made in understanding the molecular mechanisms of PF, its pathogenesis remains elusive. This review provides an in-depth exploration of the latest insights into PF pathophysiology, diagnosis, treatment, and future perspectives.

Interest & Impact

Downloads

0 since deposited on 18 Sep 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item